- Home
- IMMP vs LDI Comparison
IMMP vs LDI Comparison
Compare IMMP & LDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- LDI
- Stock Information
- Founded
- IMMP 1987
- LDI 2010
- Country
- IMMP Australia
- LDI United States
- Employees
- IMMP N/A
- LDI N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- LDI Finance: Consumer Services
- Sector
- IMMP Health Care
- LDI Finance
- Exchange
- IMMP Nasdaq
- LDI Nasdaq
- Market Cap
- IMMP 211.1M
- LDI 245.6M
- IPO Year
- IMMP N/A
- LDI 2021
- Fundamental
- Price
- IMMP $1.50
- LDI $1.11
- Analyst Decision
- IMMP Buy
- LDI Sell
- Analyst Count
- IMMP 2
- LDI 3
- Target Price
- IMMP $8.50
- LDI $1.98
- AVG Volume (30 Days)
- IMMP 84.6K
- LDI 1.2M
- Earning Date
- IMMP 05-02-2025
- LDI 05-06-2025
- Dividend Yield
- IMMP N/A
- LDI N/A
- EPS Growth
- IMMP N/A
- LDI N/A
- EPS
- IMMP N/A
- LDI N/A
- Revenue
- IMMP $3,019,249.00
- LDI $985,646,000.00
- Revenue This Year
- IMMP N/A
- LDI $32.81
- Revenue Next Year
- IMMP $20.28
- LDI $18.33
- P/E Ratio
- IMMP N/A
- LDI N/A
- Revenue Growth
- IMMP 24.11
- LDI 5.26
- 52 Week Low
- IMMP $1.32
- LDI $1.01
- 52 Week High
- IMMP $3.34
- LDI $3.23
- Technical
- Relative Strength Index (RSI)
- IMMP 39.93
- LDI 38.96
- Support Level
- IMMP $1.44
- LDI $1.01
- Resistance Level
- IMMP $1.56
- LDI $1.14
- Average True Range (ATR)
- IMMP 0.12
- LDI 0.12
- MACD
- IMMP 0.00
- LDI 0.00
- Stochastic Oscillator
- IMMP 41.63
- LDI 18.90
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.